Design of nanomaterial based systems for novel vaccine development
- 19 February 2016
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 4 (5) , 785-802
Abstract
Nanomaterials including PLGA,PPS nanoparticles, liposomes,etc.are utilized in vaccine designment to improve delivery efficiency, increase immunogenicity and effectively target tissues, cells with desirable biocompatibility.Keywords
This publication has 132 references indexed in Scilit:
- Modulating Adaptive Immune Responses to Peptide Self-AssembliesACS Nano, 2012
- Toxicology and clinical potential of nanoparticlesNano Today, 2011
- Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responsesNature Materials, 2011
- Layer-by-Layer Assembly of DNA- and Protein-Containing Films on Microneedles for Drug Delivery to the SkinBiomacromolecules, 2010
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiationNature Immunology, 2010
- Skin immune sentinels in health and diseaseNature Reviews Immunology, 2009
- Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccineProceedings of the National Academy of Sciences, 2009
- Adjuvanted H5N1 vaccine induces early CD4+T cell response that predicts long-term persistence of protective antibody levelsProceedings of the National Academy of Sciences, 2009
- Vaccine Adjuvants Alter TCR-Based Selection ThresholdsImmunity, 2008